EASL Daniel Alagille Award 2019

November 30, 2019

Featured Recent Similar


PHD PostDOC Fellowship & Research

Location (s):

  • Albania
  • Andorra
  • Armenia
  • Austria
  • Azerbaijan
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Georgia
  • Germany
  • Gibraltar
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Kosovo UN1244 (*not recognized by majority of countries)
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • North Macedonia
  • Malta
  • Moldova
  • Monaco
  • Montenegro
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Russia
  • San Marino
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • Ukraine
  • United Kingdom
  • Vatican City


EASL launched a new fellowship programme for Young Investigators entitled ‘The Daniel Alagille Award’ in honour of Pr D. Alagille.


The purpose of this fellowship is to encourage biomedical research in the field of paediatric and adult genetic cholestatic diseases sharing mutual disease-causing mechanisms.The EASL Daniel Alagille Award is generously sponsored by CTRS laboratories.

The Daniel Alagille Award is generously supported by Cell Therapies Research & Services (CTRS).    


  • Application for 'The Daniel Alagille Award' is open from 30 October to 30 November
  • Applications are reviewed by a Committee of independent experts.
  • Applicants are notified by the end of February
  • Successful applicants are requested to attend The International Liver Congress™ during which awardees are announced. The winner will receive a travel award of up to a maximum of €1,000 for this purpose and a free registration to attend the congress.
  • The winner of the Award will receive a total fund of €25,000 from the EASL for the entire research project. The award will be used exclusively to fund the award recipient's research plan as presented in the budget. Upon completion of the research, any unexpended funds will have to be notified and returned to EASL within 30 days of the day of submission of the research project to EASL.
  • Upon completion of the project, the EASL Governing Board will reserve its right to ask the award recipient to present the results of the research produced in the format / session it deems most appropriate during the International Liver Congress™.
  • In the event the award recipient is unable to complete the research or desires to discontinue the research before its completion, the award recipient will be required to return all unexpended funds within 30 days of notification and any remaining award will be cancelled.
  • After receiving the award the winner must make him/herself available to present the data of the research project within a maximal delay of 2 years
  • Submission of research progress and financial accounting reports for review by EASL are required annually.
  • Any presentation or publication of the data should mention the support of the work by the EASL Daniel ALAGILLE Award.

Application should include

  • Original project in any area of pediatric or adult genetic cholestatic diseases (max. 10 pages)
  • Detailed CV
  • Itemized budget of the project
  • Letter signed by the applicants’ senior mentor including the following elements:
    • A statement detailing the amount of work on design and research undertaken by the applicant
    • A statement that the applicate holds a Ph.D. or M.D. degree and is no more than 40 years old prior to the opening day of the International Liver Congress
    • A statement confirming that the object of the research programme is unpublished by the closing date of the application period

About EASL

EASL is a medical association dedicated to pursuing excellence in liver research, clinical practice of liver disorders, and in providing education to all those interested in hepatology. While the roots of the association were founded in Europe in 1966, EASL continues to engage globally with all stakeholders in the liver field wherever they are based. Our aim is to spread knowledge and expertise in best practices and the latest scientific breakthroughs in hepatology.

Our vision

Many Ways, One Aim: Beating Liver Disease

Our mission

EASL’s mission is to be the Home of Hepatology so that all who are involved with treating liver disease can realise their full potential to cure and prevent it. The purpose of the association is to promote communication between European workers interested in the liver and its disorders. In particular, the association shall:

  1. Promote research concerning the liver
  2. Promote education of physicians, scientists and public awareness of liver diseases and their management
  3. Act as an advisor to European and national health authorities concerning liver diseases, provision of clinical services and the need for research funding
  4. Foster European multicentre controlled trials
  5. Facilitate scientific exchange
  6. Facilitate participation of Young Investigators at its meetings

Opportunity is About:


Candidates should be from:

Description of Ideal Candidate:


  • Application should be made in English
  • Applicant must be a registered EASL member
  • Applicant must hold a M.D. or Ph.D. degree and be no more than 40 years old
  • Applicant should hold a full time position within their institution and should be working in a European institution
  • Only one submission per team will be considered and only one award will be attributed per team/institution with the period three years
  • The research programme should be feasible within one or 2 years and should not exceed two years


Deadline: November 30, 2019

Cost/funding for participants:

Amount awarded

An annual scientific award of 25,000 EUR will be provided to support a research-based project.

Find your Dream Opportunity Abroad!

Search from 6810 opportunities in 190 countries